Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

Abstract Background When the coronavirus pandemic 2019 (COVID‐19) emerged, concerns were also raised regarding the safety of allergen immunotherapy (AIT). The German Society for Allergology and Clinical Immunology (DGAKI) conducted a survey to collect real‐world data on the daily routine of administ...

Full description

Bibliographic Details
Main Authors: Oliver Pfaar, Eckard Hamelmann, Ludger Klimek, Christian Taube, Christian Vogelberg, Martin Wagenmann, Thomas Werfel, Margitta Worm
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Clinical and Translational Allergy
Subjects:
allergen immunotherapy
COVID‐19
pandemic
safety
SARS‐CoV‐2
survey
Online Access:https://doi.org/10.1002/clt2.12134

Internet

https://doi.org/10.1002/clt2.12134

Similar Items